Coherus Oncology, Inc. (CHRS)
About Coherus Oncology, Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its portfolio includes LOQTORZI which was developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, by binding to the FG loop on the PD-1 receptor. Company believe blocking PD-1 interactions with PD-L1 and PD-L2 can help to promote the immune systems.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2018
- $0
- Net income
- $168.0M
- Total assets
- $258.3M
- Market cap
- $217.5M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $217.5M
- Shares outstanding
- 203.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 6, 2014
Coherus Oncology, Inc. (CHRS) Stock Price
- Profitable — net income of $168.0M in FY2018.
- Trading 57% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Coherus Oncology, Inc..
Write a review
News about Coherus Oncology, Inc.
News & sentiment via Polygon.io
Coherus Oncology, Inc.: frequently asked questions
Is Coherus Oncology, Inc. an American company?
Coherus Oncology, Inc. is a US-based company headquartered in Redwood City, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Coherus Oncology, Inc. headquartered?
Coherus Oncology, Inc. is headquartered in Redwood City, California, United States.
Is Coherus Oncology, Inc. publicly traded?
Yes — Coherus Oncology, Inc. is a publicly traded company. Its stock trades under the ticker symbol CHRS on the NASDAQ.
What does Coherus Oncology, Inc. do?
Coherus Oncology, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
